and it is possible it could be pushed again if not ever happening. The CEO has been talking about uplisting for 3 years now and of course it hasn't happened. The CEO would be better off keeping his mouth closed and telegraphing what the company is planning on doing because it creates false expectations.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links